K. Nishide et al. / Journal of Organometallic Chemistry 682 (2003) 79Á
/84
83
4.2. Preparation of 3
4.5. X-ray crystallography
Butyllithium (1.0 mmol, 1.6 M solution in hexane, 1
X-ray diffraction data were collected on a Rigaku
RAXIS-IV imaging plate diffractometer. The structure
was solved by direct methods (SIR-92) [14], expanded
using Fourier techniques (DIRDIF-94) [15]. A symmetry-
related absorption correction using the program AB-
SCOR [16] was applied. The non-hydrogen atoms were
refined anisotropically. The hydrogen atoms were found
Mꢀ
bromopyridine (0.16 g, 1.0 mmol) in THF (20 ml) at
78 8C and was followed by the addition of chloro-
/
1 mol dmꢂ3) was added to a solution of 2-
ꢂ
/
bis(dimethylamino)phosphine (1.0 mmol). The reaction
mixture was warmed to room temperature (r.t.) and
stirred for 2 h. The solvent was removed in vacuo and
the residue was purified by silica-gel column chromato-
graphy (hexane) to afford PyP(NMe2)2 as a colorless oil
containing a small amount of the starting 2-bromopyr-
idine; 31P{1H}-NMR (162 MHz, CD2Cl2) d 99. The
crude material 3 was employed for the preparation of 5.
by the difference Fourier synthesis for 4Á6 but for 7 the
/
hydrogen atoms were generated at the calculated posi-
tions. They were refined isotropically for 5 but not
refined for 4, 6 and 7. Structure solution, refinement,
and graphical representation were carried out using the
TEXSAN package [17].
Compound 4: C22H14NO5PW, Mꢀ587.18, triclinic,
/
˚
9.455(1) A,
¯
4.3. Preparation of 5
P1 (no. 2), aꢀ
aꢀ90.625(3), bꢀ
1064.9(2) A , Zꢀ
1.831 g cmꢂ1, mꢀ5.538 mmꢂ1, F(000)ꢀ
collected reflections, 4455 unique reflections (Rint
0.095), R1ꢀ0.041 (I ꢀ2s(I)), Rwꢀ0.063 (all data),
Sꢀ1.42 (271 parameters).
Compound 5: C14H16N3O5PW, Mꢀ
clinic, P21/n (no. 14), aꢀ7.2042(5), bꢀ16.6954(7), cꢀ
96.874(2)8, Vꢀ1832.7(2) A , Zꢀ
223 K, rꢀ 6.425
1.889 g cmꢂ1, mꢀ
1000.00, 8457 collected reflections,
4163 unique reflections (Rint 0.088), R1ꢀ0.031 (I ꢀ
2s(I)), Rwꢀ0.044 (all data), Sꢀ0.94 (281 parameters).
Compound 6: C21H14NO4PW, Mꢀ559.17, ortho-
rhombic, Pnma (no. 62), aꢀ16.7705(4), bꢀ
/
9.6201(8), bꢀ
95.370(5), gꢀ
2, 2umax 55.08, Tꢀ
/
12.196(1), cꢀ
74.655(2)8, Vꢀ
296 K, rꢀ
564.00, 8535
/
/
/
/
/
3
˚
A THF solution of the crude PyP(NMe2)2, prepared
by the procedure described in Section 4.2, was stirred for
24 h with an excess amount of W(CO)5(thf) (prepared
from W(CO)6 in THF by irradiation for 12 h with a
medium-pressure 100 W Hg lamp at 0 8C). Purification
/
ꢀ
/
/
/
/
/
ꢀ
/
/
/
/
/
by column chromatography (hexaneÁAcOEt, 19:1) gave
[PyP(NMe2)2][W(CO)5] (94 mg, 18% yield based on 2-
/
/
521.12, mono-
/
/
/
3
˚
˚
bromopyridine). Compound 5: yellow crystals, m.p. 87Á
/
15.3474(6) A, bꢀ
2umax 55.08, Tꢀ
mmꢂ1, F(000)ꢀ
/
/
/4,
89 8C; 13C{1H}-NMR (101 MHz, CD2Cl2) d 41.0 (d,
ꢀ
/
/
/
/
2JPC 4.2 Hz, NMe2). H-NMR (400 MHz, CD2Cl2) d
/
1
2.84 (d, 3JPH 10.8 Hz, NMe2). Anal. Found: C, 31.84; H,
3.81; N, 6.23. Calc. for C14H16N3O5PW: C, 32.27; H,
3.09; N, 8.06%. HRMS (MARDI-TOF-MS) Found:
ꢀ
/
/
/
/
/
/
493.105. Calc. for C14H16N3O5PWÁ
/
CO: 493.039.
/
/
3
˚
˚
12.6363(5), cꢀ
2umax 55.08, Tꢀ
mmꢂ1, F(000)ꢀ
1072.00, 16 369 collected reflections,
2384 unique reflections (Rint 0.084), R1ꢀ0.030 (I ꢀ
2s(I)), Rwꢀ0.044 (all data), Sꢀ0.91 (145 parameters).
Compound 7: C13H16N3O4PW, Mꢀ493.11, triclinic,
/
9.4942(4) A, Vꢀ
/
2012.0(1) A , Zꢀ
/
4,
ꢀ
/
/
296 K, rꢀ
/
1.846 g cmꢂ1, mꢀ
/5.854
4.4. Preparation of 6 and 7
/
ꢀ
/
/
/
A THF (0.4 ml) solution of 4 (25 mg, 0.043 mmol)
was irradiated with a medium-pressure 100 W Hg lamp
at 0 8C for 30 h. The solvent was removed in vacuo and
the residue was purified by silica-gel column chromato-
/
/
/
˚
7.0926(6) A,
¯
P1 (no. 2), aꢀ
aꢀ97.282(9), bꢀ
851.1(2) A , Zꢀ
1.924 g cmꢂ1, mꢀ
collected reflections, 3478 unique reflections (Rint
0.150), R1ꢀ0.055 (I ꢀ2s(I)), Rwꢀ0.088 (all data),
Sꢀ1.31 (199 parameters).
/
8.576(1), bꢀ
108.758(9), g
2, 2umax 55.08, Tꢀ
6.907 mmꢂ1, F(000)ꢀ
/
15.399(2), cꢀ
101.364(3)8, Vꢀ
296 K, rꢀ
472.00, 6523
/
/
/
ꢀ
/
/
3
˚
graphy (hexaneÁ/AcOEt, 4:1) to afford 17 mg of 6 (70%
/
ꢀ
/
/
/
yield). Compound 6: yellow crystals, m.p. 183Á
/
185 8C;
/
/
13C{1H}-NMR (101 MHz, CD2Cl2) d 133.6 (d, JPC
ꢀ
/
2
2
14.2 Hz, o-Ph), 131.7 (s, p-Ph), 130.3 (d, JPC 37.7 Hz,
/
/
/
3
ipso-Ph), 129.5 (d, JPC 10.4 Hz, m-Ph), 128.0). Anal.
/
Found: C, 46.57; H, 3.79; N, 2.28. Calc. for
C21H14NO4PW: C, 45.11; H, 2.52; N, 2.50%. HRMS
(MARDI-TOF-MS) Found: 559.031. Calc. for
C14H16N3O5PW: 559.017. Similarly 5 (25 mg, 0.048
mmol) was irradiated in THF (0.4 ml) for 24 h at 0 8C to
afford 16 mg of 7 (68% yield). Compound 7: yellow
5. Supplementary material
Crystallographic data for the structural analysis have
been deposited with the Cambridge Crystallographic
Data Centre, CCDC nos. 210859, 210860, 210858 and
210857 for compounds 4, 5, 6 and 7, respectively. Copies
of this information may be obtained free of charge
from The Director, CCDC, 12 Union Road, Cambridge
crystals, m.p. 164Á
/
166 8C; 13C{1H}-NMR (101 MHz,
2 1
CD2Cl2) d 39.3 (d, JPC 9.6 Hz, NMe2); H-NMR (400
3
MHz, CD2Cl2) d 2.75 (d, JPH 10.9 Hz, NMe2). Anal.
Found: C, 31.57; H, 3.39; N, 8.14. Calc. for
C13H16N3O4PW: C, 31.66; H, 3.27; N, 8.52%.
CB2 1EZ, UK (Fax:
ꢁ44-1223-336066; e-mail:
/